Summary
Nephros, Inc. (Nephros) is medical device company that develops and markets high performance liquid purification filters. The company’s filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. Nephros has developed an alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). Its hemodiafiltration (HDF) system is designed for treating patients with end-stage renal disease, which removes harmful matters. Its dialysis includes Hemodiafiltration, Dialysis Water Treatment and Bicarbonate Treatment. The company provides commercial water treatment and military water treatment. Nephros is headquartered in River Edge, New Jersey, the US.
Nephros, Inc. (NEPH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Nephros, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Nephros, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Nephros, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Nephros, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Nephros, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Nephros, Inc., Medical Equipment, Deal Details 11
Partnerships 11
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters Into Licensing Agreement With Bellco 13
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 14
Nephros Enters Into Development Agreement With STERIS 15
Equity Offering 16
Nephros to Raise USD10 Million in Private Placement of Shares 16
Nephros Raises USD1.2 Million in Private Placement of Shares 18
Nephros Raises USD3 Million in Rights Offering 19
Nephros Completes Rights Offering Of Shares For US$2 Million 20
Nephros Completes Rights Offering Of Shares For US$3 Million 21
Nephros Completes Private Placement Of US$1.2 Million 22
Nephros Completes Rights Offering Of US$1.98 Million 24
Debt Offering 26
Nephros Completes Private Placement Of 12% Senior Secured Note For US$0.5 Million 26
Nephros, Inc. - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Nov 18, 2015: Nephros Announces Strategic Collaboration with Biocon 1, LLC 30
Financial Announcements 31
Mar 30, 2016: Nephros Reports 2015 Fourth Quarter and Full Year Financial Results; Provides Guidance and Potential Upcoming Milestones 31
Feb 01, 2016: Nephros Reports Preliminary 2015 Revenue and Provides Update 33
Nov 10, 2015: Nephros Reports 2015 Third Quarter Financial Results 34
Aug 10, 2015: Nephros Reports 2015 Second Quarter Financial Results 35
May 15, 2015: Nephros Reports 2015 First Quarter Financial Results 36
Apr 15, 2015: Nephros Reports 2014 Fourth Quarter and Full Year Financial Results 37
Corporate Communications 39
Dec 30, 2015: Nephros Announces Retirement of Chairman 39
Aug 17, 2015: Nephros Appoints Moshe Pinto to its Board of Directors 40
May 08, 2015: Nephros Appoints Malcolm Persen to Board of Directors 41
Apr 15, 2015: Nephros Appoints Daron Evans as President and Chief Executive Officer and Lawrence Centella as Chairman of the Board of Directors 42
Jan 07, 2015: Nephros Appoints Paul A. Mieyal as Acting Chief Executive Officer and Daron Evans as Chairman of the Board of Directors 43
Legal and Regulatory 44
May 28, 2015: Nephros Receives FDA Warning Letter 44
Product News 45
Mar 16, 2016: Nephros Launches SSUmini 45
Mar 16, 2016: Nephros Provides S100 Update 46
Jan 18, 2016: Nephros Announces Publication of Observational Trial of DSU-D in a Hospital-Based Dialysis Facility 47
Oct 22, 2015: Nephros Announces Upcoming Poster Presentation at the American Society of Nephrology's Kidney Week 2015 48
Feb 13, 2015: Nephros Clarifies the Status of Evaluation of its Hemodiafiltration System 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Tables
Nephros, Inc., Medical Equipment, Key Facts, 2014 1
Nephros, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Nephros, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Nephros, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Nephros, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Nephros, Inc., Deals By Market, 2010 to YTD 2016 9
Nephros, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters Into Licensing Agreement With Bellco 13
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 14
Nephros Enters Into Development Agreement With STERIS 15
Nephros to Raise USD10 Million in Private Placement of Shares 16
Nephros Raises USD1.2 Million in Private Placement of Shares 18
Nephros Raises USD3 Million in Rights Offering 19
Nephros Completes Rights Offering Of Shares For US$2 Million 20
Nephros Completes Rights Offering Of Shares For US$3 Million 21
Nephros Completes Private Placement Of US$1.2 Million 22
Nephros Completes Rights Offering Of US$1.98 Million 24
Nephros Completes Private Placement Of 12% Senior Secured Note For US$0.5 Million 26
Nephros, Inc., Key Competitors 27
Nephros, Inc., Key Employees 28
Nephros, Inc., Subsidiaries 29
List of Figures
Nephros, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Nephros, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Nephros, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Nephros, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Nephros, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Nephros, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Nephros, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Nephros, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9
